Affirma Biotech
Next generation immunotherapeutic drugs for the treatment of severe infections and cancer
Status
IP Type
Patent
Time
–
Countries
Coverage
Composition of matter patent, that protects a wide family of chemical products and its uses as therapeutic drugs in cancer and infections caused by viral, fungal or bacterial pathogens.
Priority date March 24th 2023
Know more of this patent
This information is confidential, do not share or copy.
You can visit their website or
Under evaluation at least till: 10th of May 2023
KEEP REVIEWING